SHIZOFRENIJA
SHIZOFRENIJA
Na globalnem nivoju shizofrenija prizadene približno 24 milijonov ljudi (8). Samo v Evropi za shizofrenijo zboli približno 3,7 milijona ljudi. Bolezen je po WHO eden izmed glavnih vzrokov za izgubljena leta zaradi nezmožnosti za delo (9, 10).
Brez učinkovitega zdravljenja je shizofrenija kronično in škodljivo stanje, ki lahko prispeva k večji umrljivosti in, še bolj pomembno, ne vpliva samo na življenje bolnika samega (11,12, 13).
V družbi Janssen smo utrli pot razvoju preprostih ter inovativnih oblik zdravljenja za bolnike s shizofrenijo. Hkrati pa še vedno nismo rešili vseh izzivov, ki jih prinaša življenje s shizofrenijo.
Reference:
[1] World Health Report. Mental disorders affects one in four people. Available atDostopno na: https://www.who.int/whr/2001/media_centre/press_release/en/. AccessedObiskano: Octoberoktober 2020.
[2] WHO. Model List of Essential Medicines. Available atDostopno na: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-.... AccessedObiskano: Nnovember 2020.
[3] Janssen. 2019. Psychiatry: Mood Disorders Portfolio. Data on file. PSY/DOF/MAY2019/EMEA001.
[4] Johnson & Johnson Innovation. Johnson & Johnson Innovation Announces 17 Collaborations With Focus on Advancing Global Healthcare Through Transformational Science and Technologies. Available atDostopno na: https://jnjinnovation.com/sites/jji/files/downloads/news/johnson_johnson.... AccessedObiskano: Nnovember 2020.
[5] WHO. Depression. Available atDostopno na: https://www.euro.who.int/en/health-topics/noncommunicable-diseases/menta.... AccessedObiskano: Nnovember 2020.
[6] Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163 (11): 1905-‒17.
[7] WHO. Depression and Other Common Mental Health Disorders. Available atDostopno na: www.who.int/mental_health/management/depression/prevalence_global_health.... AccessedObiskano: Nnovember 2020.
[8] Abi-Dargham A. Schizophrenia: overview and dopamine dysfunction. J Clin Psychiatry. 2014; 75 (11): e31. doi:10.4088/JCP.13078tx2c.
[9] Athanasopoulou, C. et al. An analysis of online health information on schizophrenia or related conditions: a cross-sectional survey. BMC Medical Informatics and Decision Making. 2013; 13 (98).
[10] Theodoridou A. & Rössler W. Disease Burden and Disability-Adjusted Life Years Due to Schizophrenia and Psychotic Disorders. In: Preedy V.R., Watson R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. 2010. https://doi.org/10.1007/978-0-387-78665-0_87.
[11] Millier A, et al. Humanistic burden in schizophrenia: A literature review. J Psych Res 2014; 54: 85–93.
[12] Bitter I, et al. Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. Eur Psychiatry 2017; 45: 97–103.
[13] Flycht L, et al. Determinants of subjective and objective burden of informal caregiving of patients with psychotic disorders. Int J Soc Psychiatry 2015; 61 (7): 684–692.
[1] World Health Report. Mental disorders affects one in four people. Available atDostopno na: https://www.who.int/whr/2001/media_centre/press_release/en/. AccessedObiskano: Octoberoktober 2020.
[2] WHO. Model List of Essential Medicines. Available atDostopno na: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-.... AccessedObiskano: Nnovember 2020.
[3] Janssen. 2019. Psychiatry: Mood Disorders Portfolio. Data on file. PSY/DOF/MAY2019/EMEA001.
[4] Johnson & Johnson Innovation. Johnson & Johnson Innovation Announces 17 Collaborations With Focus on Advancing Global Healthcare Through Transformational Science and Technologies. Available atDostopno na: https://jnjinnovation.com/sites/jji/files/downloads/news/johnson_johnson.... AccessedObiskano: Nnovember 2020.
[5] WHO. Depression. Available atDostopno na: https://www.euro.who.int/en/health-topics/noncommunicable-diseases/menta.... AccessedObiskano: Nnovember 2020.
[6] Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163 (11): 1905-‒17.
[7] WHO. Depression and Other Common Mental Health Disorders. Available atDostopno na: www.who.int/mental_health/management/depression/prevalence_global_health.... AccessedObiskano: Nnovember 2020.
[8] Abi-Dargham A. Schizophrenia: overview and dopamine dysfunction. J Clin Psychiatry. 2014; 75 (11): e31. doi:10.4088/JCP.13078tx2c.
[9] Athanasopoulou, C. et al. An analysis of online health information on schizophrenia or related conditions: a cross-sectional survey. BMC Medical Informatics and Decision Making. 2013; 13 (98).
[10] Theodoridou A. & Rössler W. Disease Burden and Disability-Adjusted Life Years Due to Schizophrenia and Psychotic Disorders. In: Preedy V.R., Watson R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. 2010. https://doi.org/10.1007/978-0-387-78665-0_87.
[11] Millier A, et al. Humanistic burden in schizophrenia: A literature review. J Psych Res 2014; 54: 85–93.
[12] Bitter I, et al. Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. Eur Psychiatry 2017; 45: 97–103.
[13] Flycht L, et al. Determinants of subjective and objective burden of informal caregiving of patients with psychotic disorders. Int J Soc Psychiatry 2015; 61 (7): 684–692.